The Current Ratio as of November 2024 (TTM) for Eyenovia, Inc. (EYEN) is 0.43

According to Eyenovia, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.43. This represents a change of -75.36% compared to the average of 1.76 of the last 4 quarters.

Eyenovia, Inc. (EYEN) Historical Current Ratio (quarterly & annually)

How has EYEN Current Ratio performed in the past?

The mean historical Current Ratio of Eyenovia, Inc. over the last ten years is 5.25. The current 0.43 Current Ratio has changed 726.00% with respect to the historical average. Over the past ten years (40 quarters), EYEN's Current Ratio was at its highest in in the March 2018 quarter at 24.89. The Current Ratio was at its lowest in in the March 2017 quarter at 0.

Eyenovia, Inc. (EYEN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Eyenovia, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Eyenovia, Inc. (EYEN) Average Current Ratio

How has EYEN Current Ratio performed in the past?

The current Current Ratio of Eyenovia, Inc. (EYEN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Eyenovia, Inc. (EYEN) Current Ratio vs. Peers

How is EYEN’s Current Ratio compared to its peers?

Eyenovia, Inc.’s Current Ratio is greater than Reviva Pharmaceuticals Holdings, Inc. (0.41), less than Cidara Therapeutics, Inc. (4.25), less than Fortress Biotech, Inc. (1.37), less than Selecta Biosciences, Inc. (1.33), greater than Reviva Pharmaceuticals Holdings, Inc. (0.41), less than Cognition Therapeutics, Inc. (3.07), less than TransCode Therapeutics, Inc. (1.25), less than Kodiak Sciences Inc. (10.59), less than BioLineRx Ltd. (1.61), less than Ardelyx, Inc. (4.03), less than Lexicon Pharmaceuticals, Inc. (11.51), less than Seres Therapeutics, Inc. (1.38), less than ImmunityBio, Inc. (3.91), less than Alpha Tau Medical Ltd. (11.66), less than Ocular Therapeutix, Inc. (16.64), less than Tenaya Therapeutics, Inc. (6.28), less than Inozyme Pharma, Inc. (9.84), less than Greenwich LifeSciences, Inc. (5.34), less than Immutep Limited (18.25), less than Anavex Life Sciences Corp. (12.04),

Build a custom stock screener for Eyenovia, Inc. (EYEN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eyenovia, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Eyenovia, Inc. (EYEN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Eyenovia, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.